NEW YORK (GenomeWeb News) - Nanosphere yesterday said third-quarter revenues fell 58 percent as R&D spending rose 37 percent and its net loss ballooned.
Total receipts for the three months ended Sept. 30 decreased to $199,000 from $468,500 year over year.
The company said product-related revenue fell to $6,125 from $89,030, and grant and contract revenue fell to $192,880 from $379,494.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.